Survey
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the work of artificial intelligence, which forms the content of this project
Pancreatic Hormones สุวัฒณี คุปติวุฒิ ตึกจุฑาธุช หอง 111 Aims Pancreatic hormones Insulin Glucagon Describe the fundamental physiological mechanisms controlling of the secretion of insulin and glucagon into the blood stream. Understand the effects of insulin and glucagon on glucose, fatty acid, and amino acid metabolism in the various body tissues. 1 Anatomy and histological of pancreas Exocrine gland: enzymes Islet of langerhans: Insulin, Glucagon Islet of Langerhans Parasympathetic fibers B cells A, α 20-30 % Glucagon B, β 60-80% D, σ ∼8% Insulin Somatostatin Sympathetic fibers D cells A cells F ∼2% Pancreatic polypeptide 2 Chain A: 21 aa Disulfide bridge Chain B: 30 aa Insulin Peptide hormone MW ∼6000 3 Preproinsulin Rough ER Proinsulin Insulin processing Insulin :: CC peptide peptide Insulin 1:1 1:1 Vesicle Golgi Processing in vesicles Cleavage of proinsulin Insulin secretion Insulin C peptide Clinical Application Hemoglobin A1C (HbA1C) • Glycosylated hemoglobin Glucose Hemoglobin HbA1C • HbA1C lives for 8-12 wks • Normal value for HbA1C = 3.5-5.5 mM 4 Uncontrolled diabetes, more glucose, much more glycosylated haemoglobin Controlled diabetes, diabetes, not much glucose, glucose, not much glycosylated haemoglobin Factor affecting insulin secretion • Glucose •Amino acids • GI hormones Mixed meal •• Diabetogenic Diabetogenic H H •• Parasympathetic Parasympathetic + + β cells Sympathetic •• Sympathetic Insulin •• Insulin Somatostatin •• Somatostatin - Insulin 5 Normal blood blood glucose glucose ∼100 ∼100 mg/dl mg/dl (3-5 (3-5 mM) mM) Normal Basal plasma insulin concentration ∼ 10 microU/ml Basal plasma insulin concentration ∼ 10 microU/ml Glucose Meals 1 st phase 2 nd phase Insulin Glucose 6 Glucoseinduced insulin secretion G ATP Ca2+ Ca2+ Ca2+ Insulin secretion ATP dependent Non ATP dependent 7 Insulin secretion GLP-1 M2 receptor GRP40 NEFA Incretin effect Incretins: GLP-1, GIP B-cells + Glucose Insulin secretion www.incretininfo.co.kr/.../incretin_diagram1.jpg 8 Insulin transport Insulin (peptide hormone) Dissolve in blood plasma Half life of insulin is less than 10 minutes Insulin Action on Cells: Dominates in Fed State Metabolism 9 Insulin signaling α−subunit containing tyrosine kinase Insulin Insulin receptor β−subunit Glucose transport Protein Lipid glycogen Growth and synthesis synthesis synthesis Gene expression Insulin actions Metabolic effect Glucose uptake Glucose usage Glycolysis Carbohydrate • Facilitates glucose transport into muscle, adipose and many other tissues but not brain • Stimulates glycogen production (glycogen synthesis) and inhibits glycogen breakdown (glycogenolysis) in liver and skeletal muscle 10 Insulin actions • inhibits glucose synthesis (gluconeogenesis) in liver Protein • Facilitates amino acids into muscle and other tissues • Stimulates protein synthesis and inhibits protein breakdown Insulin actions Lipid • Facilitates free fatty acids into cells ( lipoprotein lipase) • Promotes formation of fatty acids and glycerol from glucose • Promotes synthesis of triglyceride and inhibits their breakdown ( hormone sensitive lipase) 11 Insulin actions Growth • Promotes growth of the fetus • Promotes postnatal growth by inhibiting protein degradation • Needed for promotion of IGFs Insulin actions Protein Amino acid uptake & protein synthesis Amino acid output & amino acid oxidation CHO Glycogen synthesis Glycogenolysis Gluconeogenesis Hepatic glucose production Lipid Triglyceride synthesis Lipolysis 12 Insulin deficit Diabetes Mellitus Absolute: Insulin dependent diabetes mellitus (IDDM)/ Type I ∼ 5-10% Relative: Non insulin dependent diabetes mellitus (NIDDM)/ Type II ∼ 90-95% Defect in insulin secretion Insulin resistance Receptor Postreceptor Diagnosis Diabetes Diabetes Millitus Millitus Diagnosis ADA: American Diabetes Association •A casual plasma glucose level (taken at any time of day) of 200 mg/dL or greater when the symptoms of diabetes are present. •A fasting plasma glucose value of 126 mg/dL or greater. •An OGTT value in the blood of 200 mg/dL or greater measured at the 2-hour interval. 13 Insulin deficiency Glucose uptake Glycogenolysis Gluconeogenesis Change in blood Change in urine Protein breakdown Plasma glucose (hyperglycemia) Glucose in urine (glycosuria) glycosuria) Osmotic diuresis Sign and symptoms Frequency of urination (polyurea) polyurea) Dehydration, Thirst (polydipsia) polydipsia) Food consumption (polyphagia) polyphagia) Weight loss Insulin deficiency Lipolysis Change in blood Change in urine Plasma lipid used as fuel Ketosis Ketones in the urine (ketonurea) ketonurea) 14 Signs and symptoms of diabetes mellitus Hyperglycemia Hyperlipidemia Glucosuria (Osmotic diuresis) Ketonemia Protein wasting Weight loss Insulin excess Over dose insulin Insulinoma Hypoglycemia Neuroglycopenia Hunger Dizziness Coma Cathecolamine: anxiety, sweating, tachycardia 15 Glucagon 29 amino acids identical to enteroglucagon Glucagon act by binding to its receptor and activated G protein which cause an increase in cAMP. Glucagon has the effect of increasing blood glucose levels (opposite effect of insulin) 16 Enteroglucagon Factor affecting glucagon secretion 17 Glucagon actions Metabolic effect Carbohydrate • Stimulates breakdown of glycogen stored in the Liver and inhibits glycogen synthesis • Stimulates gluconeogenesis in the liver Glucagon actions Protein • Stimulates amino acids uptake in the liver • Stimulates protein breakdown and inhibits protein synthesis 18 Glucagon actions Lipid • Stimulates lipolysis in fat and liver • Stimulates ketone formation in the liver Glucagon actions CHO Glycogen synthesis Glycogenolysis Lipid Lipolysis Gluconeogenesis Hepatic glucose production 19 Insulin & Glucagon Regulate Metabolism Fed state insulin dominates Insulin & Glucagon Regulate Metabolism Fast state glucagon dominates 20 Low blood glucose Glucagon released by A cells of pancreas Liver releases Glucose into blood High blood glucose Insulin released by B cells of pancreas Fat cells take in glucose from blood Achieve Normal blood Glucose levels 21 Insulin and glucagon cause the tight control of blood glucose concentration Catecholamines Corticosteroids Growth H Counter regulatory hormone Glucagon excess and deficit are rare Glucagon excess: cancer of alpha cells (glucagonomas) There is no report of glucagon deficit. 22 Somatostatin Somatotrophin-release inhibiting factor (SRIF) Also found in nerve terminals and other tissues. Somatostatin is a local inhibitor of insulin and glucagon secretion. Also function as a neurotransmitter/ neuromodulator in the control of moter activity and cognitive functions. Pancreatic polypeptide (PP) 36 amino acids Secretion of PP is mainly under autonomic control. PP is released following feeding or during hypoglycaemia Role of PP is still not understood. 23